New directions with hormone therapy in prostate cancer: possible benefit from blocking prolactin and use of hormone treatment intermittently in combination with immunotherapy.
Oliver
R T
RT
Medical Oncology Department, St Bartholomew's Hospital, West Smithfield, London, UK.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D006728:Hormones / Q000627:therapeutic use*; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D008297:Male; D011388:Prolactin / Q000037:antagonists & inhibitors*; D011471:Prostatic Neoplasms / Q000628:therapy*
D006728:Hormones; D011388:Prolactin